Greenberg Traurig’s Andrew Tibbetts and Andrew Tsui Presented at MassBio 2022 Digital Health Impact Conference

Nov 08, 2022

Posted by Greenberg Traurig, LLP

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Nov 03, 2022

Posted by Sumitomo Pharma Oncology, Inc.

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia

Nov 03, 2022

Posted by Sumitomo Pharma Oncology, Inc.

EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society

Nov 03, 2022

Greenberg Traurig’s Jeffrey W. Greene Named a ‘Massachusetts Go To Lawyer: Cybersecurity and Data Privacy 2022’

Nov 02, 2022

Posted by Greenberg Traurig, LLP

Greenberg Traurig’s Mian R. Wang Elected to MCLE Board of Trustees

Nov 01, 2022

Posted by Greenberg Traurig, LLP

Greenberg Traurig’s Lauren A. Liss Moderated MassEcon Forum Panel

Oct 28, 2022

Posted by Greenberg Traurig, LLP